Recordati Rare Diseases North America
Carlos Geraldo is an experienced professional in the pharmaceutical and healthcare industries, currently serving as an Endo Account Lead and Orphan Drug Specialist at Recordati Rare Diseases Inc. since March 2022. Carlos has demonstrated expertise in disease awareness programs, stakeholder education, and event organization across public and private sectors in various regions of Brazil. Previous roles include Sales Representative positions at Sandoz and a Sales Consultant for Rare Diseases at IQVIA, where significant results were achieved in identifying patients with hATTR. Carlos's career began with roles in medical propaganda and sales, supplemented by a strong educational background, including an MBA in Strategic Business Management from Centro Universitário FMU | FIAM-FAAM.
This person is not in any offices
Recordati Rare Diseases North America
1 followers
Recordati Rare Diseases Inc. (RRD) markets products to treat rare diseases. RRD is a member of the Recordati Group, which includes Recordati S.p.A., Orphan Europe, among other companies around the globe. The Recordati Group, which was established in 1926 currently employs more than 4,000 worldwide. The RRD mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases.